We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The European Commission (EC) has granted approval for the proposed acquisition of Swiss-based pharmaceuticals and biotechnology company Actelion by Johnson & Johnson.
Johnson & Johnson Innovation LLC has announced 15 new collaborations spanning promising scientific areas, including 3D printing, the microbiome and immunotherapy. These collaborations, which are focused on developing novel healthcare solutions in areas of